NASDAQ:TEM - Nasdaq - US88023B1035 - Common Stock - Currency: USD
62.43
-1.31 (-2.06%)
The current stock price of TEM is 62.43 USD. In the past month the price increased by 44.41%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TMO | THERMO FISHER SCIENTIFIC INC | 18.89 | 156.19B | ||
DHR | DANAHER CORP | 26.55 | 141.54B | ||
A | AGILENT TECHNOLOGIES INC | 21.37 | 32.35B | ||
IQV | IQVIA HOLDINGS INC | 12.83 | 25.56B | ||
MTD | METTLER-TOLEDO INTERNATIONAL | 29.31 | 24.72B | ||
WAT | WATERS CORP | 30.4 | 21.54B | ||
WST | WEST PHARMACEUTICAL SERVICES | 32.44 | 15.48B | ||
ILMN | ILLUMINA INC | 25.29 | 13.33B | ||
RVTY | REVVITY INC | 18.98 | 11.24B | ||
ICLR | ICON PLC | 9.63 | 10.90B | ||
QGEN | QIAGEN N.V. | 18.57 | 9.23B | ||
AVTR | AVANTOR INC | 13.34 | 9.18B |
Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. The company is headquartered in Chicago, Illinois and currently employs 2,400 full-time employees. The company went IPO on 2024-06-14. The firm provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Its product lines include genomics, data, and artificial intelligence applications (AI). Its genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction (PCR), profiling, molecular genotyping, and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
TEMPUS AI INC
600 West Chicago Avenue, Suite 510
Chicago ILLINOIS US
Employees: 2400
Phone: 18009765448
The current stock price of TEM is 62.43 USD. The price decreased by -2.06% in the last trading session.
The exchange symbol of TEMPUS AI INC is TEM and it is listed on the Nasdaq exchange.
TEM stock is listed on the Nasdaq exchange.
16 analysts have analysed TEM and the average price target is 63.35 USD. This implies a price increase of 1.48% is expected in the next year compared to the current price of 62.43. Check the TEMPUS AI INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
TEMPUS AI INC (TEM) has a market capitalization of 10.80B USD. This makes TEM a Large Cap stock.
TEMPUS AI INC (TEM) currently has 2400 employees.
TEMPUS AI INC (TEM) has a support level at 62.42 and a resistance level at 65.49. Check the full technical report for a detailed analysis of TEM support and resistance levels.
The Revenue of TEMPUS AI INC (TEM) is expected to grow by 78.88% in the next year. Check the estimates tab for more information on the TEM EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
TEM does not pay a dividend.
TEMPUS AI INC (TEM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.3).
The outstanding short interest for TEMPUS AI INC (TEM) is 20.38% of its float. Check the ownership tab for more information on the TEM short interest.
ChartMill assigns a technical rating of 7 / 10 to TEM.
ChartMill assigns a fundamental rating of 3 / 10 to TEM. TEM has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months TEM reported a non-GAAP Earnings per Share(EPS) of -1.3. The EPS decreased by -338.03% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -46.74% | ||
ROE | -221.13% | ||
Debt/Equity | 2.45 |
ChartMill assigns a Buy % Consensus number of 75% to TEM. The Buy consensus is the average rating of analysts ratings from 16 analysts.
For the next year, analysts expect an EPS growth of 71.86% and a revenue growth 78.88% for TEM